PNC Financial Services Group Inc. Has $88.71 Million Stock Position in Colgate-Palmolive (NYSE:CL)

PNC Financial Services Group Inc. trimmed its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 0.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 975,812 shares of the company's stock after selling 4,251 shares during the quarter. PNC Financial Services Group Inc. owned 0.12% of Colgate-Palmolive worth $88,711,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. D Orazio & Associates Inc. grew its stake in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock valued at $297,000 after acquiring an additional 108 shares during the period. Commonwealth Financial Services LLC grew its position in shares of Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after purchasing an additional 118 shares during the period. Lantz Financial LLC increased its stake in Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after purchasing an additional 122 shares in the last quarter. Horizon Kinetics Asset Management LLC raised its holdings in Colgate-Palmolive by 4.2% during the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock worth $322,000 after buying an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc lifted its stake in Colgate-Palmolive by 1.0% in the fourth quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock valued at $1,182,000 after buying an additional 130 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Barclays lowered their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. Piper Sandler dropped their price target on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. Morgan Stanley reduced their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, January 8th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and a consensus target price of $101.61.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded down $2.81 during midday trading on Tuesday, hitting $94.69. 1,694,091 shares of the company's stock were exchanged, compared to its average volume of 4,144,716. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $76.85 billion, a PE ratio of 26.95, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company's 50 day moving average price is $88.97 and its 200 day moving average price is $95.06.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the business earned $0.87 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.11%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.